Biopharma and Vaccines

Cultivate Excellence in Ontario: Where Biopharma and Vacccines Drive Discoveries

Take charge in Ontario, a top hub for biopharmaceutical advancements, where global leaders and innovative startups discover and bring life-changing innovations to market. Benefit from top talent, world-class research partners, and strong R&D support. Shape the future of biopharma and vaccines right here in Ontario, where your ideas can make a real difference.

A measurable difference

$1.82 billion

invested in R&D by Ontario’s research hospitals

#1

largest life sciences jurisdiction in Canada

$77B+

revenue in Ontario’s life sciences sector in 2022

72,800

life sciences workers in Ontario in 2022

12.5B

Ontario’s life sciences exported goods in 2022

61.7%

of total Canadian life sciences sector exports

~2,000

Ontario life sciences firms (44% of Canada’s total)

Get the Prescription for Success in Ontario

Engage Our Experts

An R&D Powerhouse

Experience thriving clinical trials and rapid commercialization of cutting-edge therapies in Ontario. Benefit from cost advantages, a diverse population, and streamlined processes, making Ontario ideal for your biomanufacturing needs. Notably, all of the world’s top ten pharmaceutical companies, including Johnson & Johnson, Roche, Novartis, Merck & Co, Pfizer, conduct clinical trials in Ontario. Witness groundbreaking investment, like OmniaBio's $580 million in Brampton, advancing Canada's cell and gene therapy manufacturing capabilities.

Ontario’s Biopharma Talent Pool

Leverage Ontario's pool of top-tier medical and scientific talent to drive your biopharmaceutical business forward. With a steady influx of over 65,000 STEM graduates annually and a robust academic ecosystem focusing on biotechnology and life sciences, Ontario provides a rich talent pool for your company's growth and innovation needs. Tap into this skilled workforce to advance your biopharma initiatives and propel your business to new heights of success.

$3.39 billion

attracted by Ontario Universities for research

25,000+

researchers employed by Ontario’s research hospitals

A Uniquely Collaborative Ecosystem

Engage with Ontario's collaborative innovation ecosystem, where industry, academia, and government converge to catalyze revolutionary advancements in biopharmaceuticals. Partner with world-renowned research institutions to pioneer discoveries and leverage government initiatives supporting research translation into clinical applications.

Ontario's fertile ground has witnessed pioneering breakthroughs like insulin, the first meningitis vaccine for infants, the first HIV vaccine, and the prototype of 3D bioprinting to print artificial skin, Join this transformative landscape to revolutionize the biopharmaceutical industry and propel your business to new heights of success.

OmniaBio Inc. will be a game-changer for Ontario and Canada. It will provide missing infrastructure to allow Ontario and Canadian cell and gene companies to remain here, while also attracting foreign companies. Cell and gene therapy is Canada’s opportunity to be global leaders in life sciences. Investing in manufacturing is a key driver, and we’re grateful to Invest Ontario for its leadership and foresight.

Michael May

Chair, OmniaBio Inc.